Antioxidants modulate the IL-6 induced inhibition of negative acute-phase protein secretion in HepG2 cells.
Despite increasing evidence on the potential of dietary antioxidants in modulating the etiology of certain chronic diseases such as cancer and cardiovascular diseases, little is known about their beneficial role in acute-phase responses and inflammatory diseases. From this viewpoint the aim of this study was to investigate the effect of selected dietary antioxidants in modulating the secretion of negative acute-phase proteins caused by interleukin-6 (IL-6) in HepG2 cells. Cells were first stimulated with a fixed dose of IL-6 for 24 h then incubated for a further 8 h with varying concentrations of eight antioxidants, alpha-lipoic acid (LA), (-)-epicatechin (EC), (-)-epicatechin gallate (ECG), (-)-epigallocatechin (EGC), (-)-epigallocatechin gallate (EGCG), alpha-tocopherol (TOC), ascorbic acid (AA) and N-acetylcysteine (NAC). The culture supernatants were assayed for transthyretin (TTR) and retinol binding protein (RBP) using ELISA. The data revealed that IL-6 significantly reduced TTR and RBP secretion compared with the basal production. All tested antioxidants attenuate the reduction in TTR and RPB levels. The strongest effects were achieved with the highest concentration of each antioxidant. The order of effect were LA > EGCG > ECG > TOC > EGC > EC > NAC > AA. In conclusion, these results provide evidence that the dietary antioxidants can play a fundamental role in inflammatory processes.
el-Saadany
Mohamed A
MA
Department of Physiology and Pathophysiology, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee, Potsdam-Rehbrücke, Germany.
Rawel
Harshadrai M
HM
Raila
Jens
J
el-Dashloty
Mohamed S
MS
Schweigert
Florian J
FJ
D000209:Acute-Phase Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D000975:Antioxidants / Q000502:physiology*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D045744:Cell Line, Tumor; D006801:Humans; D015850:Interleukin-6 / Q000502:physiology*; D008099:Liver / Q000378:metabolism*; D011228:Prealbumin / Q000378:metabolism; D012177:Retinol-Binding Proteins / Q000378:metabolism; D008063:Thioctic Acid / Q000502:physiology; D000093242:Interleukin-6 Inhibitors
D000209:Acute-Phase Proteins; D000975:Antioxidants; D015850:Interleukin-6; D011228:Prealbumin; D012177:Retinol-Binding Proteins; D008063:Thioctic Acid; D000093242:Interleukin-6 Inhibitors